-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MVOprzwtaUXKKuZ7Wa00OYaCo0P0+nH/YUdmYgd2XH63ng4FU3a6smH0X9hSj+Zu 6Nbw2ZZ0VqAUck9zNHpCJw== 0000849043-07-000175.txt : 20071221 0000849043-07-000175.hdr.sgml : 20071221 20071221170651 ACCESSION NUMBER: 0000849043-07-000175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20071220 FILED AS OF DATE: 20071221 DATE AS OF CHANGE: 20071221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROGEN CORP CENTRAL INDEX KEY: 0000849043 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222845714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034888201 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KRAUSE JAMES CENTRAL INDEX KEY: 0001177841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 071324000 MAIL ADDRESS: STREET 1: 35 NE INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-12-20 0000849043 NEUROGEN CORP NRGN 0001177841 KRAUSE JAMES 35 NE INDUSTRIAL RD. BRANFORD CT 06405 0 1 0 0 Senior VP Biology Stock Option (Right to Buy) 3.56 2007-12-20 4 A 0 15750 0 A 2008-12-20 Common Stock .025 Par Value Per Share 15750 15750 D On 12/20/2007 the reporting person was granted an option to purchase 15,750 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 4 equal annual installments and expire 5 years from each vesting date. Option was granted under an employee stock option plan, for no consideration. /s/Stephen R. Davis, by power of attorney 2007-12-21 EX-24 2 krause.htm 
                  POWER OF ATTORNEY









 The undersigned hereby appoints Stephen R. Davis, EVP

and Chief Business Officer of Neurogen Corporation, his or her

attorney-in-fact and agent in any and all capacities to execute

for and on his or her behalf filings with the Securities and

Exchange Commission on Forms 3, 4 or 5 pursuant to Section 16

of the Securities and Exchange Act of 1934, as amended, to the

extent that such filings relate to the undersigned's status as

a director or officer of Neurogen Corporation.  The undersigned

further appoints Stephen R. Davis his or her attorneyin fact

and agent to execute any and all amendments to such filings as

such attorney-in-fact and agent deems appropriate.  The

undersigned hereby grants to such attorney-in-fact and agent

full power and authority to do and perform each and every act

necessary or desirable as the undersigned could do in person,

hereby ratifying and confirming all that such attorney in fact

and agent may lawfully do or has done by virtue hereof.



This Power of Attorney shall become effective as of September 1, 2002.





/s/ JAMES KRAUSE

___________________________

James Krause
-----END PRIVACY-ENHANCED MESSAGE-----